Dana Zakalik

4PUBLICATIONS
20CO-AUTHORS
Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 28, 2026
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Adriana I Apostol, Jacek Gronwald, Cezary Cybulski

|Aug 03, 2021
Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update.

Nadine M Tung, Dana Zakalik, Mark R Somerfield

Pageof 1